TORONTO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Dividend Select 15 Corp. (the “Company”) announces it has renewed its at-the-market equity program (“ATM Program”) that allows the Company to issue shares of ...
TORONTO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Financial 15 Split Corp. (the “Company”) announces it has renewed its at-the-market equity program (“ATM Program”) that allows the Company to issue shares of ...
TORONTO, Jan. 22, 2026 (GLOBE NEWSWIRE) — Dividend Select 15 Corp. (the “Company”) announces it has renewed its at-the-market equity program (“ATM Program”) that allows the Company to issue shares of ...
TORONTO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- TDb Split Corp. (the “Company”) announces it has renewed its at-the-market equity program (“ATM Program”) that allows the Company to issue shares of the ...
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- (TSX: LBS, LBS.PR.A) Life & Banc Split Corp. (the "Fund”) is ...
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- (TSX: DGS, DGS.PR.A) Dividend Growth Split Corp. (the “Fund”) is ...
Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- (TSX: PWI, PWI.PR.A) Power & Infrastructure Split Corp. (the "Fund” ...
Multiple Solid Tumor Settings to Be Pursued with Clinical Trials Expected to Start in Mid-2026 MIAMI--(BUSINESS WIRE)-- Summit Therapeutics Inc. (SMMT) today announced it has entered into a clinical ...
MIAMI--(BUSINESS WIRE)-- Summit Therapeutics Inc. (SMMT) (“Summit,” “we,” or the “Company”) today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results